| 2/1/2021 |
Biosensor Applications |
loire-net.tv |
... detect analytes. These instruments have a wide range of applications ranging from clinical through to environmental and agricultural. The devices are also used in the food industry.Some examples of the fields that use biosensor technology include: General healthcare monitoring Clinical analysis and diagnosis of disease Veterinary and agricultural applications Industrial processing and monitoring Environmental pollution controlBiosensors can provide cost-effective, easy-to-use, sensitive and highly accurate detection ... |
| 1/11/2021 |
ACC.21 to offer remote COVID-19 screening |
cardiacrhythmnews.com |
... BioSticker and medical-grade BioButton wearable devices allow for continuous vital sign monitoring of temperature, heart rate and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics.In a statement, ACC said that its 2021 scientific session will bring together cardiologists and cardiovascular specialists from around the world to share the newest discoveries in treatment and prevention. ACC ... |
| 1/11/2021 |
BioIntelliSense collaborates with American College of Cardiology to Advance Remote Cardiac Care |
cardiology2.com |
... BioSticker and medical-grade BioButton wearable devices allow for continuous vital sign monitoring of temperature, heart rate and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics. The strategic collaboration will combine ACC’s clinical expertise in heart health with BioIntelliSense’s effortless user experience and multi-parameter monitoring to make remote cardiac care scalable, reliable, and cost ... |
| 1/11/2021 |
BioIntelliSense and the American College of Cardiology join forces to advance remote cardiac care |
dotmed.com |
... BioSticker and medical-grade BioButton wearable devices allow for continuous vital sign monitoring of temperature, heart rate and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics. The strategic collaboration will combine ACC's clinical expertise in heart health with BioIntelliSense's effortless user experience and multi-parameter monitoring to make remote cardiac care scalable, reliable, and cost effective.ACC ... |
| 1/4/2021 |
[ASAP] Structure-Guided Discovery of Silicon-Containing Subnanomolar Inhibitor of Hydroxyphenylpyruvate Dioxygenase as a Potential Herbicide |
acs.org |
... of Silicon-Containing Subnanomolar Inhibitor of Hydroxyphenylpyruvate Dioxygenase as a Potential Herbicide Ren-Yu Qu Ren-Yu Qu Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, Central China Normal University, Wuhan 430079, P. R. China Jia-Xu Nan Jia-Xu Nan Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, International Joint Research Center ... |
| 12/15/2020 |
BioIntelliSense BioButton‚Ñ¢ Named CES 2021 Best of Innovation Award Honoree |
Business Insider |
... cleared BioButton is a coin-sized, disposable medical wearable device for continuous monitoring of temperature, heart rate and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics. Its effortless user experience design and multi-parameter capability makes remote monitoring scalable, reliable and cost effective."We are extremely honored to be named Best of Innovation as a CES 2021 ... |
| 12/10/2020 |
New serological assay provides rapid, accurate testing for SARS-CoV-2 antibodies |
sciencedaily.com |
2 New serological assay provides rapid, accurate testing for SARS-CoV-2 antibodies Using optical biosensor technology , the test provides quantitative measurements of antibodies in blood plasma in less than 20 minutes Date: University of California - Santa Cruz Summary: Researchers have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19. Researchers say the new method is as accurate as ... |
| 11/23/2020 |
VitalConnect Announces the Launch of VitalPatch® RTM, a First-of-its-kind Extended Holter Technology for Cardiac Monitoring |
Business Wire |
SAN JOSE, Calif.- VitalConnect ® , Inc., a leader in remote and in-hospital wearable biosensor technology , announced today it has launched its VitalPatch RTM cardiac monitoring solution for patients who require extended Holter monitoring. VitalPatch RTM monitors for 21 cardiac arrhythmias through a unique AI-based ECG analysis solution and captures data on four key vital signs, providing a more complete view of a patient’s condition. Patient data is ... |
| 11/23/2020 |
VitalConnect Announces the Launch of VitalPatch® RTM, a First-of-its-kind Extended Holter Technology for Cardiac Monitoring |
itbusinessnet.com |
In combination with its newly opened independent diagnostic testing facility, VitalConnect is advancing how patients are monitored for cardiac arrhythmias SAN JOSE, Calif.–(BUSINESS WIRE)– VitalConnect ® , Inc., a leader in remote and in-hospital wearable biosensor technology , announced today it has launched its VitalPatch RTM cardiac monitoring solution for patients who require extended Holter monitoring. VitalPatch RTM monitors for 21 cardiac arrhythmias through a unique AI-based ... |
| 11/23/2020 |
VitalConnect Announces the Launch of VitalPatch® RTM, a First-of-its-kind Extended Holter Technology for Cardiac Monitoring |
BioSpace |
VitalConnect Announces the Launch of VitalPatch® RTM, a First-of-its-kind Extended Holter Technology for Cardiac MonitoringPublished: Nov 23, 2020 SAN JOSE, Calif.--( BUSINESS WIRE )-- VitalConnect ® , Inc., a leader in remote and in-hospital wearable biosensor technology , announced today it has launched its VitalPatch RTM cardiac monitoring solution for patients who require extended Holter monitoring. VitalPatch RTM monitors for 21 cardiac arrhythmias through a unique AI ... |
| 11/23/2020 |
VitalConnect announces the launch of VitalPatch RTM, a first-of-its-kind extended Holter technology for cardiac monitoring |
dotmed.com |
SAN JOSE, Calif.--(BUSINESS WIRE)--VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology , announced today it has launched its VitalPatch RTM cardiac monitoring solution for patients who require extended Holter monitoring. VitalPatch RTM monitors for 21 cardiac arrhythmias through a unique AI-based ECG analysis solution and captures data on four key vital signs, providing a more complete view of a patient’s condition. Patient ... |
| 11/9/2020 |
New Rapid COVID-19 Point of Care Test |
pr.com |
... identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy. Atlanta, GA, November 09, 2020 --( PR.com )-- Pepex Biomedical, Inc. is a leading developer of enzymatic biosensor technology focused on enabling healthier lives across the globe. Historically focused on diagnostic blood glucose measuring systems, Pepex has recently pivoted to apply its proprietary sensor platform to the development of immunological sensors specific to ... |
| 11/6/2020 |
Archer commences development of A1 Biochip for simplifying disease detection |
technologyforyou.org |
... A1 Biochip Image: Archer MaterialsArcher Materials has announced the commencement of development for its lab-on-a-chip device, the A1 Biochip.“Archer has made a step-change in advancing its graphene-based biosensor technology development to newly commence its lab-on-a-chip A1 Biochip project,” the company told shareholders in a statement issued to the ASX.The company said it was possible in a short period ... |
| 11/5/2020 |
Aussie Deep-Tech Company Commences Unique A1 Biochip Build |
azosensors.com |
Small-cap, deep-tech company Archer Materials Limited has announced the building of a lab-on-a-chip device named A1 Biochip‚Ñ¢.Having recently hired lab-on-a-chop Biotechnologist Dr. Rebecca Soffe, the Archer team have made a step-change in advancing its graphene-based biosensor technology development to newly commence its lab-on-a-chip A1 Biochip‚Ñ¢. Developing the biochip in-house should allow Archer to ... |
| 11/4/2020 |
Oral Cancer Rapid Test Kit Market: Advent of New Immunoassay-based Technologies has Expanded the Potential in the Market |
BioSpace |
... The great value that point-of-care diagnostics play in general well-being of patients offers a broad impetus also to the expansion of the oral cancer rapid test kit market. Advances made in biosensor technology has helped stakeholder see new revenues streams in the market. A case in point is lab-on-a-chip.Manufacturers in the oral cancer rapid test kits market over the years have put increasing ... |
| 9/2/2020 |
Archer Material adds to graphene-based biosensor technology by producing it with 3D printing |
proactiveinvestors.com |
... technology to build proof-of-concept cartridge components for Archer’s biosensor devices. Mohammad talks about why this step is so important as the company looks to accelerate progress towards commercialising Archer’s innovative graphene-based biosensor technology. Quick facts: Archer Materials Ltd Price: 0.65 AUD ... |
| 9/2/2020 |
Shedding New Light on GPCR Drug Discovery with a Novel Biosensor Technology |
genengnews.com |
... signaling paradigms and are not sufficiently nuanced to address the various dimensions of GPCR signaling. In this GEN webinar, our expert panelists will introduce bioSensAll , an enhanced bystander bioluminescence resonance energy transfer (ebBRET)-based biosensor technology that addresses bottlenecks limiting current GPCR drug discovery and development efforts. Through various examples, our presenters will discuss how novel GPCR pharmacology concepts can be revealed by this new biosensor technology to advance drug ... |
| 8/31/2020 |
Archer Materials announces proof-of-concept cartridge components for graphene biosensor device |
graphene-info.com |
Archer Materials announces proof-of-concept cartridge... Archer Materials announces proof-of-concept cartridge components for graphene biosensor device Archer Materials has progressed its graphene-based biosensor technology development by successfully prototyping key device hardware using additive manufacturing (3D printing). Graphene-based biosensor devices 2D printed on a circuit board that has been incorporated into the custom-designed and 3D printed cartridge made from ABS. The cartridge is opened and ... |
| 8/18/2020 |
Efferent Labs and Gore Announce Development Collaboration |
PR Newswire |
... developing cutting edge materials for the life science industry," said Bill Rader , CEO at Efferent. "We feel that they have the proper resources to help us continuously evolve the cellular environment in our implantable biosensor technology for use in both animal research and our future applications in human therapeutics." "This collaborative effort is an inspiring opportunity to contribute Gore's advanced material and biointerface capabilities to support Efferent Labs' mission to ... |
| 8/16/2020 |
Watching changes in plant metabolism — live |
healthmedicinet.com |
... at the University of Münster with the participation of the University of Bonn are studying key mechanisms in the regulation of energy metabolism. Now, for the first time, a new method of in vivo biosensor technology has enabled them to monitor in real time what effects environmental changes – for example, light, temperature, aridity, flooding or pest infestation – have on the central metabolism of the model plant Arabidopsis thaliana (thale cress ... |